TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for ... (NGX267 our muscarinicagonist in xerostom...)

TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel

Date:10/1/2008

NGX267, our muscarinic agonist, in xerostomia secondary to Sjogren's syndrome."

About Tezampanel and NGX426

Tezampanel is the first AMPA/kainate-type glutamate receptor antagonist to be studied in clinical trials for chronic pain, including migraine. Glutamate receptors mediate the functioning of glutamate, an important excitatory neurotransmitter. While normal glutamate production is essential, excess glutamate production, either through injury or disease, can have a range of pathological effects. By acting at both the AMPA and kainate receptor site to competitively block the binding of glutamate, tezampanel and its oral prodrug, NGX426, have the potential to treat a number of diseases and disorders. These include migraine and other forms of chronic pain such as neuropathic pain and fibromyalgia, as well as muscle spasticity and rigidity, thrombosis and epilepsy.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates, each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity, xerostomia and cognitive disorders. The company is currently developing four product candidates: two ionotropic glutamate receptor antagonists and two muscarinic receptor agonists. Further information is available at http://www.torreypinestherapeutics.com.

This press release contains forward-looking statements or predictions. Such forward-looking statements include, but are not limited to, statements regarding the timing for initiating a Phase III program for tezampanel in acute migraine, the potential for tezampanel and NGX426 as treatments for acute migraine and o
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/14/2009)... Dec. 14 Dyadic International, Inc. (Pink ... extended its collaboration with The Scripps Research Institute ... to re-annotate the genome of Dyadic,s patented and ... a continuation of the successful relationship between the ... Dyadic engaged Scripps to annotate the C1 genome ...

(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 Lionbridge ... it has signed a new, three-year master ... company with products and services that serve ... agreement Lionbridge will become the sole provider ... which includes regulatory, marketing, training, human resources, ...

(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...

(Date:12/11/2009)... Researchers have discovered a new explanation for differences in the ... of a certain gene, the more serious the handicap. The ... suspected that it is the amount of copies of the ... in the American Journal of Human Genetics , and ... Froyen connected to VIB, a life sciences research institute in ...

Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2 Dyadic International Extends Collaboration With The Scripps Research Institute 3 Dyadic International Extends Collaboration With The Scripps Research Institute 4 Dyadic International Extends Collaboration With The Scripps Research Institute 5 Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2 Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3 Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2 Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3 Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4 Amount of gene surplus determines severity of mental retardation in males 2

[0] Dyadic International Extends Collaboration With The Scripps Research Institute [0] Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement [0] Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas [0] Amount of gene surplus determines severity of mental retardation in males

... VANCOUVER, July 14 /PRNewswire/ - OncoGenex Technologies Inc. ... with the U.S. Food and Drug,Administration (FDA) on ... of,OGX-011, its lead product candidate targeting hormone refractory ... In the letter,responding to the OncoGenex submission, the ...

... plug-in for popular embedded tool suite. , ... ... Systems, Inc., a leading supplier of configurable and scalable real-time ... for the RTXC Quadros RTOS is now available for the ...

... Bioheart, Inc.,(Nasdaq: BHRT ) a ... that help monitor, diagnose and treat heart ... Owens, Director,Clinical Affairs, will assume responsibility for ... MyoCell(R) Therapy clinical,trials from Richard T. Spencer, ...

Other Biology Technology:OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011 2 OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011 3 OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011 4 OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011 5 OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011 6 RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 2 RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 3 RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger 4 Bioheart, Inc., Announces Management Change 2 Bioheart, Inc., Announces Management Change 3

OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011 RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger Bioheart, Inc., Announces Management Change

(Date:12/15/2009)... has just signed an agreement with the British Society ... affiliation with the journal Biogerontology for an ... appoint one member of the Biogerontology editorial ... annually. Springer will sponsor the society and provide ... on www.springerlink.com . , Biogerontology ...

(Date:12/15/2009)... Ghent, 15 December 2009 - Scientists at VIB and ... ally for the treatment of septic shock, the major ... the release of nitric oxide (NO) gas in mice ... discovered that the animal,s organs showed much less damage, ... to all expectations, since it is generally assumed that ...

(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...

Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2 Story of 4.5 million-year-old whale unveiled in Huelva 2 Story of 4.5 million-year-old whale unveiled in Huelva 3 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 1 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 2 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 3 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 4 Breast Abnormality Follow Up Often Later in Black Women 60080 1 Breast Abnormality Follow Up Often Later in Black Women 60080 2 Donate Life Illinois Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend Walter Payton 60075 1 Donate Life Illinois Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend Walter Payton 60075 2 Donate Life Illinois Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend Walter Payton 60075 3 Donate Life Illinois Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend Walter Payton 60075 4

[0] Springer signs agreement with British Society of Research on Ageing [0] Septic shock: Nitric oxide beneficial after all [0] Story of 4.5 million-year-old whale unveiled in Huelva

... large-scale genetic study of native North Americans offers new insights ... from their subarctic home in northwest North America to the ... trace, is believed to have occurred about 500 years ago. ... of Illinois, is detailed this month in the American ...

... in the nest. But if you don,t, you pay a ... eggs from their own has long puzzled scientists. The problem ... eyes. It was only when people started thinking from the ... a cuckoo egg in the nest. Marcel Honza from the ...

... Scientists from The University of Texas M. ... tissue type transglutaminase (TG2) in ovarian cancer is associated ... chemotherapy and lower overall survival rates. When researchers targeted ... reversed, suggesting the protein may also provide a novel ...

Other Biology News:Y chromosome study sheds light on Athapaskan migration to southwest US 2 Y chromosome study sheds light on Athapaskan migration to southwest US 3 How birds spot the cuckoo in the nest 2 TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer 2 TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer 3

Y chromosome study sheds light on Athapaskan migration to southwest US How birds spot the cuckoo in the nest TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer

Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...

Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....

Biology Products:

Lentiviral Vector Manufacture from Lentigen Chicken IgG ELISA Kit from Bethyl Laboratories Cat IgM ELISA Kit from Bethyl Laboratories Bovine IgM ELISA Kit from Bethyl Laboratories

TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for ...(NGX267 our muscarinicagonist in xerostom...)